{"nct_id":"NCT06319170","title":"Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2024-03-28","start_date_type":"ACTUAL","primary_completion_date":"2025-01-15","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-15","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TEVA"]}